Evidence map›Paper›PMID 41001472›Full record

ArticlemedRxiv : the preprint server for health sciences2025

The genetic architecture of fibromyalgia across 2.5 million individuals.

Isabel Kerrebijn, Gyda Bjornsdottir, Keon Arbabi, Lea Urpa, Hele Haapaniemi, Gudmar Thorleifsson, Lilja Stefansdottir, Stephan Frangakis, Jesse Valliere, Lovemore Kunorozva and 45 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

55 authors.

Isabel KerrebijnLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.ORCID 0000-0001-8894-250X
Gyda BjornsdottirAmgen deCODE Genetics, Reykjavik, Iceland.ORCID 0000-0002-8100-0306
Keon ArbabiLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.ORCID 0000-0003-3219-8835
Lea UrpaStanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.ORCID 0000-0002-8712-3518
Hele HaapaniemiInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Gudmar ThorleifssonAmgen deCODE Genetics, Reykjavik, Iceland.
Lilja StefansdottirAmgen deCODE Genetics, Reykjavik, Iceland.
Stephan FrangakisDepartment of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, USA.
Jesse ValliereStanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
Lovemore KunorozvaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0003-4262-6696
Erik AbnerInstitute of Genomics, Estonian Genome Center, University of Tartu, Tartu, Estonia.ORCID 0000-0002-6529-3161
Caleb JiLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.ORCID 0009-0007-7459-7646
Bitten AagaardDepartment of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0001-8306-1332
Henning BliddalThe Parker Institute, Copenhagen University Hospital Bispebjerg Frederiksberg, Denmark.
Søren BrunakDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-0316-5866
Mie T BruunClinical Immunology Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Maria DidriksenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-4856-496X
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0001-6551-6647
Arni J GeirssonDepartment of Rheumatology, Landspitali University Hospital, Reykjavik, Iceland.
Daniel F GudbjartssonAmgen deCODE Genetics, Reykjavik, Iceland.
Thomas F HansenNeurogenomics, Translational Research Centre, Copenhagen University Hospital, Glostrup, Denmark.ORCID 0000-0001-6703-7762
Ingileif JonsdottirAmgen deCODE Genetics, Reykjavik, Iceland.
Stacey KnightIntermountain Medical Center, Intermountain Heart Institute, Salt Lake City, UT, USA.
Kirk U KnowltonIntermountain Medical Center, Intermountain Heart Institute, Salt Lake City, UT, USA.
Christina MikkelsenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-2945-6197
Lincoln D NadauldIntermountain Healthcare, Saint George, UT, USA.
Thorunn A OlafsdottirAmgen deCODE Genetics, Reykjavik, Iceland.
Sisse R OstrowskiDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-5288-3851
Ole Bv PedersenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-2312-5976
Saedis SaevarsdottirAmgen deCODE Genetics, Reykjavik, Iceland.
Astros T SkuladottirAmgen deCODE Genetics, Reykjavik, Iceland.ORCID 0000-0002-5048-0933
Erik SørensenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-5002-9077
Hreinn StefanssonAmgen deCODE Genetics, Reykjavik, Iceland.
Patrick SulemAmgen deCODE Genetics, Reykjavik, Iceland.
Olafur A SveinssonSchool of Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Gudny E ThorlaciusAmgen deCODE Genetics, Reykjavik, Iceland.
Unnur ThorsteinsdottirAmgen deCODE Genetics, Reykjavik, Iceland.
Henrik UllumStatens Serum Institut, Copenhagen, Denmark.ORCID 0000-0001-7306-9058
Arnor VikingssonDepartment of Rheumatology, Landspitali University Hospital, Reykjavik, Iceland.
Thomas M WergeDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Chronic Pain Genomics Consortium
FinnGen
DBDS Genomic Consortium
Estonian Biobank Research Team
Genes & Health Research Team
Richa SaxenaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Kari StefanssonAmgen deCODE Genetics, Reykjavik, Iceland.
Chad M BrummettDepartment of Anesthesiology, Michigan Medicine, Ann Arbor, MI, USA.ORCID 0000-0003-0974-7242
Bente GlintborgDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-8931-8482
Daniel J ClauwChronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.
Thorgeir E ThorgeirssonAmgen deCODE Genetics, Reykjavik, Iceland.
Frances Mk WilliamsDepartment of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, UK.ORCID 0000-0002-2998-2744
Nasa Sinnott-ArmstrongHerbold Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0003-4490-0601
Hanna M OllilaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Michael WainbergLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.

Funding

Technology to understand genetic variant effects in contextRM1HG010461 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Bruce Colston Trapnell · 2019 to 2026
$18.9M
Genetic Markers of Chronic Postsurgical PainK08AR082454 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Stephan Frangakis · 2023 to 2026
$697k
NHGRI NIH HHS RM1 HG010461NIAMS NIH HHS K08 AR082454
6 · The paper itself

Abstract

Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here, we conduct a multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals (54,629 cases and 2,509,126 controls) from 11 cohorts, identifying the first 26 risk loci for fibromyalgia. The strongest association was with a coding variant in HTT, the causal gene for Huntington's disease. Gene prioritization implicated the HTT regulator GPR52, as well as diverse genes with neural roles, including CAMKV, DCC, DRD2/NCAM1, MDGA2, and CELF4. Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types. Fibromyalgia showed strong, positive genetic correlation with a wide range of chronic pain, psychiatric, and somatic disorders, including genetic correlations above 0.7 with low back pain, post-traumatic stress disorder and irritable bowel syndrome. Despite large sex differences in fibromyalgia prevalence, the genetic architecture of fibromyalgia was nearly identical between males and females. This work provides the first robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities.

Identifiers

PMID41001472
PMCPMC12458511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.